{
    "2021-04-27": [
        [
            {
                "time": "2021-04-27",
                "original_text": "智飞生物涨5.3%报207.96元 成交额27.44亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "涨幅",
                        "成交额"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "“海啸式”疫情冲击印度，多家医药公司回应，五大券商把脉后市",
                "features": {
                    "keywords": [
                        "印度疫情",
                        "医药公司",
                        "券商分析"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "虽然三叶草生物作为新冠疫苗的黑马，但目前重组蛋白亚单位新冠疫苗，距离上市最近的并非三叶草生物。",
                "features": {
                    "keywords": [
                        "三叶草生物",
                        "新冠疫苗",
                        "重组蛋白"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "重组蛋白亚单位新冠疫苗爆发之际 三叶草生物赴港IPO谋突围？",
                "features": {
                    "keywords": [
                        "重组蛋白",
                        "新冠疫苗",
                        "IPO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "智飞生物等9股获特大单资金净流入超2亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "资金流入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "众机构扎堆追涨、实控人突然减持 智飞生物博弈新高 减持股份数量较大",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "减持",
                        "机构追涨"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "长春高新的“隐疾”：传统业务见顶 重销售轻研发",
                "features": {
                    "keywords": [
                        "长春高新",
                        "隐疾",
                        "研发"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "同心防疫 携手共进｜智飞生物与碧迪医疗签署战略合作协议",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "碧迪医疗",
                        "战略合作"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "923亿资金争夺20股：主力资金重点出击10股(名单)",
                "features": {
                    "keywords": [
                        "资金争夺",
                        "主力资金",
                        "股票名单"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}